We Provide
Trusted, Ethical, and
Transparent Research
Reducing our patients’ symptoms of chronic pain through high quality medical research.
Advanced Medical Equipment. World Class Chronic Pain Management. Innovative Scientific Research.
Services
Clinical trials
Protocol Consulting
Ethics Review Board Consults
Support
Data Analysis
Medical Writing
Protocol Design & Review
About
Allevio
Answers
Allevio Answers’ core purpose is innovative research with a keen interest in not only reducing our patients’ symptoms of chronic pain but improving their overall quality of life. Over the past 3 years, Allevio has championed the cause of opioid reduction among pain patients through novel multidisciplinary research.
Our vision is to be on the cutting edge of comprehensive pain management solutions by combining pain treatment and research, with the aim of relieving pain-related suffering. We are dedicated to the advancement of our collective knowledge about pain through innovative research, with a keen focus on patient-centric treatment interventions.
Research
Chronic pain affects a third of all Canadians, when compounded with the negative impacts of opiate use and misuse, this represents an immense cost to both the individual and society as a whole.
Allevio has conducted one of the largest retrospective studies on ketamine-lidocaine infusions as a treatment for pain, which has shown promising results. The study examined over 170 chronic pain patients undergoing a ketamine-lidocaine infusion protocol over a treatment period of 36 weeks. The overwhelming majority of patients experienced reductions in pain, improvements to their mood and quality of life. Most patients, who were using opioid narcotic painkillers, reduced their opioid use with many patients ceasing opioid use.
Improving Chronic Pain Patient Outcomes Through Innovative Chronic Pain Management
The project aims to improve chronic pain treatment by further studying and expanding Allevio’s multidisciplinary practice while improving the accessibility of pain specialists to Canadians through an innovative virtual and remote care platform.